NCT07396220
Psychotherapy Combined With Intranasal Esketamine for the Treatment of Suicidal Ideation
Enrolling by Invitation
NAAges 18–70InterventionalTreatmentUniversity of California, San DiegoInvestigator-initiated
~56 participants
Updated 2026-02-09 on ClinicalTrials.gov
What's tested:Naturalistic Intranasal EsketamineBrief Cognitive Behavioral Therapy for Suicide Prevention
At a glance
Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Beck Scale for Suicidal Ideation
Measured over 1-week post treatment
+1 more outcome measured
Conditions
Where it's being run
1 sites across 1 statesCalifornia1
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
What this trial measures
- Beck Scale for Suicidal Ideation1-week post treatment
- TMS-EEG N100 peak1-week post treatment